Research Ethics and Policy Series (REPS): Ethical Issues in Psychedelics Research
12:00pm - 1:00pm • RCH B102AB, Richards Building, 3700 Hamilton Walk
2023-01-11 12:00:00 2023-01-11 13:00:00 America/New_York Research Ethics and Policy Series (REPS): Ethical Issues in Psychedelics Research Ethical Issues in Psychedelics Research Dominic Sisti, PhD Associate Professor of Medical Ethics & Health Policy; Associate Professor of Psychiatry; Associate Professor of Philosophy, Perelman School of Medicine, University of Pennsylvania; Director, Scattergood Program for Applied Ethics in Behavioral Health Care Lunch is provided for in-person attendees. Livestreaming available via Zoom. Against the backdrop of mental health crises and widespread diseases of despair, psychedelic drugs have emerged as promising treatments for several psychiatric conditions including severe depression, anxiety, post-traumatic stress disorder, suicide, and addiction. In this talk, I will describe ethical and professional challenges that, unless addressed, will expose participants (and eventually patients) to unnecessary risk and will undermine scientific progress. These include questions related to obtaining informed consent for transformative experiences and the protection of vulnerable persons in non-ordinary states. I will offer recommendations for policy and professionalism to advance ethical research in this emerging field. REPS events are now on the 2nd Wednesdays, September-June. RCH B102AB, Richards Building, 3700 Hamilton Walk Penn Medical EthicsEthical Issues in Psychedelics Research
Dominic Sisti, PhD
Associate Professor of Medical Ethics & Health Policy; Associate Professor of Psychiatry; Associate Professor of Philosophy, Perelman School of Medicine, University of Pennsylvania; Director, Scattergood Program for Applied Ethics in Behavioral Health Care
Lunch is provided for in-person attendees.
Livestreaming available via Zoom.
Against the backdrop of mental health crises and widespread diseases of despair, psychedelic drugs have emerged as promising treatments for several psychiatric conditions including severe depression, anxiety, post-traumatic stress disorder, suicide, and addiction. In this talk, I will describe ethical and professional challenges that, unless addressed, will expose participants (and eventually patients) to unnecessary risk and will undermine scientific progress. These include questions related to obtaining informed consent for transformative experiences and the protection of vulnerable persons in non-ordinary states. I will offer recommendations for policy and professionalism to advance ethical research in this emerging field.
REPS events are now on the 2nd Wednesdays, September-June.